Literature DB >> 14986816

Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C.

Matthias J Bahr1, Mohamed el Menuawy, Klaus H W Boeker, Petra B Musholt, Michael P Manns, Ralf Lichtinghagen.   

Abstract

BACKGROUND: The speed of fibrosis progression varies considerably between patients with chronic hepatitis C. This study analyzed whether cytokine gene polymorphisms are associated with a progressive course of the disease.
METHODS: Leukocyte DNA from 101 patients with chronic hepatitis C, 52 patients with hepatitis C virus (HCV)-induced cirrhosis and 200 Caucasian blood donors was prepared. Using PCR, RFLP and PAGE, gene polymorphism analysis of the interleukin (IL)1alpha( - 889), IL1beta( - 511 and +3954), IL1 receptor agonist (RA)(intron2 VNTR), IL4(intron3 VNTR) and TNFalpha( - 308) loci was performed.
RESULTS: Of the polymorphisms analyzed, IL1beta( - 511) and IL1RA(intron2 VNTR) were unevenly distributed between the study groups. The IL1 (- 511)*A2A2 genotype occurred significantly more often in chronic hepatitis C and HCV-induced liver cirrhosis than in the controls (P < 0.01, P < 0.05, respectively). Patients with HCV-induced cirrhosis displayed a significantly higher frequency of the IL1RA(intron2 VNTR)*A2 polymorphism than patients with chronic hepatitis C and controls (P < 0.05).
CONCLUSIONS: Although the IL1beta( - 511)*A2A2 genotype may increase the susceptibility to acquire chronic hepatitis C and IL1RA(intron2 VNTR)*A2 polymorphism is associated with disease progression to cirrhosis, our results indicate that the analyzed cytokine gene polymorphisms have an overall low impact on the natural course of chronic hepatitis C infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14986816     DOI: 10.1111/j.1478-3231.2003.00873.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  11 in total

1.  Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis.

Authors:  Fabio Farinati; Romilda Cardin; Marina Bortolami; Maria Guido; Massimo Rugge
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

2.  Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver disease.

Authors:  Elisabetta Fontanini; Annarosa Cussigh; Carlo Fabris; Edmondo Falleti; Pierluigi Toniutto; Davide Bitetto; Sara Cmet; Elisa Fumolo; Ezio Fornasiere; Sara Bignulin; David J Pinato; Rosalba Minisini; Mario Pirisi
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

Review 3.  HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis.

Authors:  Rabia Nawaz; Sadia Zahid; Muhammad Idrees; Shazia Rafique; Muhammad Shahid; Ammara Ahad; Iram Amin; Iqra Almas; Samia Afzal
Journal:  Inflamm Res       Date:  2017-03-11       Impact factor: 4.575

Review 4.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 5.  Recognition of genetic factors influencing the progression of hepatitis C : potential for personalized therapy.

Authors:  Julie R Jonsson; David M Purdie; Andrew D Clouston; Elizabeth E Powell
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 6.  Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: an intricate pathway.

Authors:  Romilda Cardin; Marika Piciocchi; Marina Bortolami; Andromachi Kotsafti; Luisa Barzon; Enrico Lavezzo; Alessandro Sinigaglia; Kryssia Isabel Rodriguez-Castro; Massimo Rugge; Fabio Farinati
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

Review 7.  Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better?

Authors:  David Burgner; Sarra E Jamieson; Jenefer M Blackwell
Journal:  Lancet Infect Dis       Date:  2006-10       Impact factor: 25.071

8.  Role of host genetics in fibrosis.

Authors:  Georgina L Hold; Paraskevi Untiveros; Karin A Saunders; Emad M El-Omar
Journal:  Fibrogenesis Tissue Repair       Date:  2009-12-04

9.  Impact of IL-10 (-1082) promoter-single nucleotide polymorphism on the outcome of hepatitis C virus genotype 4 infection.

Authors:  Soheir F Helal; Howayda E Gomaa; Eman H Thabet; Mariam A Younan; Neveen A Helmy
Journal:  Clin Med Insights Gastroenterol       Date:  2014-04-01

10.  Influence of cytokine and cytokine receptor gene polymorphisms on the degree of liver damage in patients with chronic hepatitis C.

Authors:  Sara Tatiana Moreira; Giovanni Faria Silva; Camila Fernanda Verdichio de Moraes; Rejane Maria Tomasini Grotto; Maria Inês de Moura Campos Pardini; Maria da Graça Bicalho; Ricardo Alberto Moliterno
Journal:  Meta Gene       Date:  2016-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.